- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04858438
Pain After Insufflation for Robotic Sacrocolpopexy (PAIRS) Trial
April 23, 2021 updated by: Ascension South East Michigan
This study evaluates post-operative pain between different insufflation pressures during robotic-assisted sacrocolpopexy.
Subjective pain and narcotic usage after surgery will be measured.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This is a prospective single-blind randomized controlled trial of adult women undergoing robotic-assisted sacrocolpopexy for pelvic organ prolapse.
Each surgery will be performed by a board-certified Female Pelvic Medicine & Reconstructive Surgery (FPMRS) surgeon with a standard technique other than pneumoperitoneum level.
A sacrocolpopexy for apical prolapse may be performed at the same time as a hysterectomy and other clinically indicated procedures if desired by the patient and as part of the standard of care.
Patients will be stratified by hysterectomy prior to randomization.
Postoperatively, patients will be evaluated with a Visual Analogue Scale (VAS) as well as prescribed narcotic analgesic use and followed up to 2 weeks.
Study Type
Interventional
Enrollment (Anticipated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Gabriella Rustia, MD
- Phone Number: 313-343-6708
- Email: gabriella.rustia@ascension.org
Study Contact Backup
- Name: Muhammad F Aslam, MD
- Phone Number: 313-343-3494
- Email: muhammad.aslam@ascension.org
Study Locations
-
-
Michigan
-
Detroit, Michigan, United States, 48236
- Recruiting
- Ascension St. John Hospital
-
Contact:
- Gabriella M Rustia, MD
- Email: gabriella.rustia@ascension.org
-
Contact:
- Muhammad F Aslam, MD
- Email: muhammad.aslam@ascension.org
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Scheduled to have a robotic-assisted sacrocolpopexy surgery for pelvic organ prolapse.
- Age 18-90 years
- Can read and understand the consent form and consents to the procedure
Exclusion Criteria:
- Patients undergoing other procedures
- Patients who do not consent to participate.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Standard Insufflation Group
Patients will receive standard insufflation during surgery (15 mm Hg).
|
This is the amount of insufflation using during the surgical procedure.
|
|
Experimental: Low Insufflation Group
Patients will receive a lower level of insufflation during surgery (12 mm Hg or lower).
|
This is the amount of insufflation using during the surgical procedure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post-operative Pain on a visual analogue scale, ranging from 1-10 with a higher score meaning more pain.
Time Frame: Pain will be assessed within 24 hours of the surgery. .
|
Pain will be assessed during the 24-hour post-operative period.
|
Pain will be assessed within 24 hours of the surgery. .
|
|
Post-operative Pain on a visual analogue scale, ranging from 1-10 with a higher score meaning more pain.
Time Frame: Pain will be assessed at the two-week post-operative follow-up visit.
|
Pain will be assessed during the two-week post-operative period.
|
Pain will be assessed at the two-week post-operative follow-up visit.
|
|
Safety using Operation length, blood loss, need to increase insufflation, operative conversion rates. These are all counts with higher numbers meaning worse outcomes.
Time Frame: Safety will be assessed during the procedure.
|
The safety of the lower insufflation pressure will be assessed during the procedure.
|
Safety will be assessed during the procedure.
|
|
Safety using Operation length, blood loss, need to increase insufflation, operative conversion rates. These are all counts with higher numbers meaning worse outcomes.
Time Frame: Safety will be assessed immediately post-operatively.
|
The safety of the lower insufflation pressure will be assessed immediately post-operatively.
|
Safety will be assessed immediately post-operatively.
|
|
Safety using Operation length, blood loss, need to increase insufflation, operative conversion rates. These are all counts with higher numbers meaning worse outcomes.
Time Frame: Safety will be assessed at the two-week follow-up visit.
|
The safety of the lower insufflation pressure will be assessed at the two-week follow-up visit.
|
Safety will be assessed at the two-week follow-up visit.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 2, 2021
Primary Completion (Anticipated)
May 1, 2022
Study Completion (Anticipated)
December 31, 2022
Study Registration Dates
First Submitted
April 16, 2021
First Submitted That Met QC Criteria
April 20, 2021
First Posted (Actual)
April 26, 2021
Study Record Updates
Last Update Posted (Actual)
April 27, 2021
Last Update Submitted That Met QC Criteria
April 23, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1716019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pelvic Organ Prolapse
-
NICHD Pelvic Floor Disorders NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingPelvic Organ Prolapse | Pelvic Organ Prolapse Vaginal Surgery | Pelvic Organ Prolapse, Patient Education | Pelvic Organ Prolapse (POP)United States
-
Hillel Yaffe Medical CenterCompletedHysterectomy | Pelvic Organ Prolapse Vaginal Surgery | Pelvic Organ Prolapse (POP)Israel
-
University of CalgaryAlberta Health services; Cook Group IncorporatedCompletedAnterior Pelvic Organ ProlapseCanada
-
Wolfson Medical CenterRecruiting
-
Queen's UniversityNot yet recruitingPelvic Organ Prolapse (POP)Canada
-
Coloplast A/SCompletedPelvic Organ Prolapse (POP)United States
-
Chung Shan Medical UniversityActive, not recruitingPelvic Organ Prolapse | Pelvic Organ Prolapse Vaginal Surgery | Sacrocolpopexy | PectopexyTaiwan
-
A.M.I. Agency for Medical Innovations GmbHActive, not recruitingProlapse | Pelvic Organ Prolapse (POP) | SacrocolpopexyGermany
-
University of British ColumbiaCompletedPelvic Organ Prolapse, Patient EducationCanada
-
University of MelbourneCompletedVaginal Hysterectomy | Pelvic Organ Prolapse Vaginal SurgeryAustralia
Clinical Trials on Insufflation during surgery
-
Chang Gung Memorial HospitalCompletedCarbon Dioxide Insufflation During Colonoscopy
-
University Hospital MuensterUnknownInflammatory Bowel DiseasesGermany
-
Vitkovice HospitalCompletedInflammatory Bowel DiseaseCzech Republic
-
Ankara UniversityCompletedLaparoscopic SurgeryTurkey
-
Gachon University Gil Medical CenterCompletedGastric TumorKorea, Republic of
-
Second Xiangya Hospital of Central South UniversityNot yet recruiting
-
Bordeaux Colorectal Institute AcademyRecruitingColorectal Surgery | Benign or Malignant Rectal or Colon TumorsFrance
-
Sheba Medical CenterTerminatedMorbid Obesity | Hypothermia | Bariatric Surgery CandidateIsrael
-
Rennes University HospitalCompletedCardiopulmonary BypassFrance
-
Guangdong Provincial People's HospitalNot yet recruitingPatient Reported Outcome Measures | Pulmonary Surgical ProceduresChina